Mental Health and Addictions


  • Acknowledgements
  • Introduction
    • Additional Reports
    • Provincial Overview
  • Deaths
    • Trend
    • Demographics
    • By RHA
  • Hospitalizations / ED Presentations
    • Inpatient Admissions
    • Emergency Department Presentations
  • WFPS Attended Events
    • Trend
    • Demographics
    • By Neighbourhood Cluster
  • Take-Home Naloxone Distribution
  • Glossary
    • Abbreviations
    • Diagnosis Codes


Acknowledgements

We acknowledge our office is located on Treaty 1 Territory and that Manitoba is located on the Treaty Territories and ancestral lands of the Anishinaabeg, Anishininewuk, Dakota Oyate, Denesuline and Nehethowuk Nations.

We acknowledge Manitoba is located on the Homeland of the Red River Métis.

We acknowledge northern Manitoba includes lands that were and are the ancestral lands of the Inuit.

We respect the spirit and intent of Treaties and Treaty Making and remain committed to working in partnership with First Nations, Inuit and Métis people in the spirit of truth, reconciliation and collaboration.


Introduction

This interactive report, provides up-to-date information on substance use and related harms in Manitoba. Four key data sources and corresponding metrics are displayed, which are used in the ongoing surveillance of substance-related harms. This dashboard will be updated mid-month, each quarter (Jan, Apr, Jul, Oct), and will include information up to the end of the previous quarter, if available.

These four data sources include:

Office of the Chief Medical Examiner (OCME).

  • The OCME is the data source for substance-related deaths. In an effort to provide timely information these deaths are assessed based on toxicological findings prior to the completion of a finalized autopsy, and are therefore subject to change as more information becomes available.

Hospital Data - Two Sources.

  1. Discharge Abstracts Database (DAD), is the source for all substance related in-patient admissions. These are identified as patients who have had at least one substance-related discharge diagnosis. The availability of this data source can be 3-6 months behind as it undergoes additional validation before being released.
  2. Emergency Department Information System (EDIS), is the source for all substance-related emergency department (ED) visits. These are identified as either having a substance-related discharge diagnosis, or by a keyword search in the ED visit reason field. This data source is updated on an ongoing basis. This data set however, does not fully cover all ED’s within Manitoba. Only ED’s that are connected to EDIS are included, which means some smaller rural ED’s are left out from this source.

Emergency Medical Services (EMS) - Winnipeg Fire and Paramedic Service (WFPS) Data

Take-Home Naloxone (THN) Kit distribution data

  • Data is obtained in the Public Health Information Management System (PHIMS), which tracks the distribution of take-home naloxone kits to their distribution sites throughout the Province. This data source is updated on an ongoing basis.


Provincial Overview


Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-2024100120140160180Q4-2020Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-202411501200125013001350140014501500
QuarterQuarterNumber of DeathsSubstance-related AdmissionsDeaths*Substance Related Admissions
Q4-2020Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-2024Q3-2024Q4-2024500600700800900Q4-2020Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-2024Q3-2024Q4-20242k4k6k8k10k12k14k16k
QuarterQuarterWFPS Attended EventsNaloxone Kits DistributedWFPS Overdose EventsNaloxone Kits Distributed

*Substance-related death data is subject to change as more information becomes available. This may mean that the most recent data may be underrepresented.

Quarters are defined by calendar quarters. I.e. Q1: Jan - Mar, Q2: Apr - Jun, Q3: Jul - Sep, Q4: Oct - Dec.



Deaths


Trend

Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-202405010015020001020304050
BenzodiazepinesStimulantsOpioidsConfirmed FatalitiesSubstance-related DeathsQuarterNumber of Substance-related DeathsSubstance-related Deaths /100,000

*Confirmed fatality counts (bars) are based on the left axis, while crude rates (line graph) are based on the right axis.


The trend of co-involvement of multiple substances in the deaths reported continued in Q2 2024. Also, the proportions of deaths contributed by specific substance classes followed the same pattern as in Q1, with stimulants contributing the most to the deaths while benzodiazepines contributed the least. Of the 158 deaths reported from April to June 2024, stimulants, largely methamphetamine and cocaine, contributed 118 deaths (74.7%); while opioids, largely fentanyl, contributed 110 deaths (69.6%). Bromazolam was implicated in virtually all the 59 deaths associated with benzodiazepines (57, 96.6%).


Definition: Substance-related deaths are deaths due entirely, or at least in part, to the toxic effects of one or more substances, including alcohols. A death is considered opioid related if at least one of the substances contributing to causing death is an opioid. It is important to note that deaths due to the effects of chronic substance abuse, or deaths due to other causes where substance intoxication may have circumstantially contributed (i.e., drunk driving, hypothermia, drownings), are excluded from this case definition.



Demographics

0501001502000-1920-2930-3940-4950-5960+
FemaleMaleDemographic distribution of substance-related deathsSubstance-related Deaths/100,000
  • For January 2022 to June 2024
  • Displayed as crude rate per 100,000 Manitoba residents.


By RHA

  • Under Construction



Hospitalizations / ED Presentations


Inpatient Admissions

Q4-2020Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-2024050010001500
AlcoholCocaineOpioidsOther DepressantsOther StimulantsTotalSubstance-related Inpatient AdmissionsQuarterSubstance-related Hospital Admissions
  • Please see glossary for definition of categories.


Emergency Department Presentations

Q4-2020Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-2024Q3-2024Q4-20240100020003000
AlcoholCocaineOpioidsOther DepressantsOther StimulantsTotalEmergency Department PresentationsQuarterED Presentations
  • Please see glossary for definition of categories.
  • Categories are defined by the ED discharge diagnosis provided in EDIS.
  • Note that a discharge diagnosis is not always provided, and thus this may be an under-representation of the actual number within each category. The total however, includes all identified substance-related
    presentations, whether a diagnosis code was provided or not.


Q4-2020Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-2024Q3-2024Q4-202412001250130013501400145015001550
Emergency Department Overdose PresentationsQuarterED Overdose Presentations
  • ED overdose presentations are identified in EDIS using a keyword search in the ED chief complaint field.



WFPS Attended Events


Trend

Q4-2020Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-2024Q3-2024Q4-2024050010001500200025003000
AlcoholCocaineCrystal MethMarijuanaOpioidsTotalSubstance-related IncidentsQuarterSubstance-related Incidents
  • Categories are defined by WFPS, as the main cause for the need for WFPS personnel to attend an event.


Q4-2020Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-2024Q3-2024Q4-2024500600700800900
Suspected Opioid Overdose EventsQuarterOverdose Events
  • Suspected opioid overdose events are WFPS-attended events where Naloxone/Narcan was administered.


Demographics

050010001500200025000-1920-2930-3940-4950-5960+
FemaleMaleSuspected Overdose Cases responded by WFPSOverdose Events /100,000AgeGroup
  • For October 2024 to December 2024 inclusive.
  • Displayed as crude rate per 100,000 Winnipeg residents.


By Neighbourhood Cluster

Events /100,000
02,0004,0006,000

Leaflet | © OpenStreetMap contributors © CARTO
  • For October 2024 to December 2024 inclusive.
  • Displayed as crude rate per 100,000 residents.
  • Geo-coded as the neighbourhood cluster that the event was responded to at. Not necessarily the neighbourhood cluster of residence for the person being responded to.



Take-Home Naloxone Distribution

Q4-2020Q1-2021Q2-2021Q3-2021Q4-2021Q1-2022Q2-2022Q3-2022Q4-2022Q1-2023Q2-2023Q3-2023Q4-2023Q1-2024Q2-2024Q3-2024Q4-202405k10k15k
Interlake-EasternNorthernPrairie MountainSouthernWinnipegTotalTake-Home Naloxone Kits Distributed By RHA of Holding PointQuarterNaloxone Kits Distributed

Note that holding points are not necessarily the final point of distribution of the take-home naloxone kits. Also, a person from one RHA may obtain a kit from another RHA, so this is not a fully accurate picture of where each take-home naloxone kit is eventually kept and/or used.


Glossary

Abbreviations

DAD: Discharge Abstracts Database

ED: Emergency Department

EDIS: Emergency Department Information System

EMS: Emergency Medical Services

OCME: Office of the Chief Medical Examiner

PHIMS: Public Health Information Management System

Q1-Q4: Quarters one through four, as defined by calendar quarters. I.e. Q1: Jan - Mar, Q2: Apr - Jun, Q3: Jul - Sep, Q4: Oct - Dec.

THN: Take-Home Naloxone

WFPS: Winnipeg Fire and Paramedic Service


Diagnosis Codes

Hospital and ED related substance diagnoses are categorized using the International Classification of Diseases 10th revision (ICD-10) diagnoses codes. These are:

  • Alcohol:
    • F10.1 - F10.9: Alcohol-related disorders
    • T51.0-T51.9: Toxic effect of alcohol
    • X45.0-X45.9: Accidental poisoning by and exposure to alcohol
    • X65.0-X65.0: Intentional self-poisoning by and exposure to alcohol
    • Y15.0-Y15.9: Poisoning by and exposure to alcohol, undetermined intent
  • Cocaine:
    • F14.0-F14.9: Cocaine-related disorders
    • T40.5: Poisoning by cocaine
  • Opioids:
    • F11.1-F11.9: Opioid abuse/dependence
    • T40.0: Poisoning by opium
    • T40.1: Poisoning by heroin
    • T40.2: Poisoning by other opioids
    • T40.3: Poisoning by methadone
    • T40.3: Poisoning by other narcotics
    • T40.4: Poisoning by synthetic narcotics
    • T40.6: Poisoning by unspecified narcotics
  • Other Depressants:
    • F13.10-F13.19: Sedative-hypnotic-, or anxiolytic-related disorders
    • T42.3: Poisoning by barbiturates
    • T42.4: Poisoning by benzodiazepines
    • T42.6: Poisoning by other antiepileptic and sedative-hypnotic drugs
    • T42.7: Poisoning by antiepileptic and sedative-hypnotic drugs, unspecified.
  • Other Stimulants:
    • F15.1-F15.9: Other stimulant-related disorders
    • T43.6: Poisoning by psychostimulants